BioEscalator · Aug 2024
Confirms YC acceptance and says the company would receive funding plus advice/support to continue R&D.
Making Next-Generation Antibiotics that Outpace Bacterial Evolution
Company research
Public company, workplace, funding, and market signals
Updated Jul 30, 2026
Overview
Oxford-based biotech startup founded in 2021 that is building AI- and evolution-informed precision antibiotics to outpace bacterial resistance; it is small, founder-led, and YC S24-associated. Public funding sources are a little inconsistent, but the company profile most directly indicates $625K total raised across a $125K Seed and a $500K Pre-Seed.
Primary product
AI-powered precision-antibiotics discovery platform
Founded
2021
Headquarters
Oxford, Oxfordshire, United Kingdom
Team size
1-10
Industry
Biotechnology
Sub-industry
Antibiotic discovery
Offices
Oxford, United Kingdom (BioEscalator / Old Road Campus)
Open Positions
0 jobs at Evolvere BioSciences
No open positions
Check back later for new openings